SEARCH RESULTS FOR: "Tag: ALXN"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2017(8)
2016(9)
2015(5)
CATEGORIES
Analyst Downgrades(2)
Analyst Update(3)
Analyst Upgrades(1)
Best and Worst Stocks(2)
Buzz Stocks(2)
By the Numbers(5)
Editor's Pick(1)
Expectational Analysis(2)
General(2)
Indexes and ETFs(2)
Intraday Option Activity(1)
Opening View(2)
Quantitative Analysis(3)
Stocks On the Move(2)

10/24/2017 10:04 AM
Analysts are weighing in on biotech Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), TV streaming service Netflix, Inc. (NASDAQ:NFLX), and online retail giant Amazon.com, Inc. (NASDAQ:AMZN). Here's a qu...
9/26/2017 12:46 PM
Last month we featured Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) as two stocks to watch in September, as both biotechs historically outperformed for ...
8/28/2017 12:29 PM
Biotechs are buzzing today on news of Gilead Sciences' $12 billion buyout of cancer specialist Kite Pharma Inc (NASDAQ:KITE). While KITE's 28% surge serving as a tailwind for the sector, drug stocks ...
6/27/2017 1:37 PM
Biotech stocks have been hot lately, with the SPDR S&P Biotech ETF (XBI) flirting with annual highs. What's more, the exchange-traded fund (ETF) is one of the best to own in the month of July, histor...
6/14/2017 9:59 AM
Fed meetings obviously have a major impact on a number of sectors, including bank and housing stocks. One group that isn't usually discussed around Fed time is drug stocks, but that's going to change...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center